Table 1.
Descriptive characteristics of participants and differences between groups at the baseline of fibromyalgia patients.
| Variable | Exercise Group Median (IQR) | Control Group Median (IQR) | Value of the Contrast | p-Value |
|---|---|---|---|---|
| Sample size | 25 | 25 | ||
| Age (Years) | 54.00 (16.00) | 53.00 (13.00) | −0.351 | 0.800 |
| Height (cm) | 160.00 (11.00) | 159.00 (7.00) | −0.351 | 0.800 |
| Weight (Kg) | 69.30 (16.20) | 72.35 (19.40) | −0.470 | 0.800 |
| BMI (Kg/m²) | 27.00 (4.30) | 28.35 (7.40) | −0.650 | 0.800 |
| FIQ-100 | 57.58 (28.47) | 63.90 (23.56) | −0.490 | 0.800 |
| Years with FM | 8.50 (10.75) | 11.00 (10.25) | −0.308 | 0.800 |
| pVO2 (ml/Kg/min) | 23.77 (4.24) | 24.46 (5.38) | −0.019 | 0.985 |
| MMSE | 29.00 (1.00) | 28.50 (2.25) | −2.151 | 0.460 |
| Left Hippocampus | 3.04 (0.43) | 2.93 (0.36) | −1.660 | 0.460 |
| Right Hippocampus | 3.08 (0.31) | 3.07 (0.33) | −0.760 | 0.800 |
| Left Insula | 3.35 (2.06) | 3.34 (2.49) | −0.919 | 0.800 |
| Right Insula | 3.82 (1.70) | 4.28 (1.21) | −0.809 | 0.800 |
| Left Amygdala | 1.37 (0.19) | 1.41 (0.16) | −0.319 | 0.800 |
| Right Amygdala | 1.63 (0.18) | 1.64 (0.22) | −0.873 | 0.800 |
| Left Thalamus | 7.83 (0.94) | 7.51 (0.61) | −1.532 | 0.477 |
| Right Thalamus | 7.07 (0.81) | 6.81 (0.66) | −1.724 | 0.460 |
| Left Cerebellum | 48.37 (9.92) | 46.12 (8.09) | −0.958 | 0.800 |
| Right Cerebellum | 51.39 (13.14) | 49.04 (11.27) | −1.681 | 0.460 |
| Total Cerebral GM | 436.10 (72.50) | 428.35 (126.54) | −0.319 | 0.800 |
Abbreviations: IQR, interquartile range; BMI, body mass index; FIQ, fibromyalgia impact questionnaire; FM, fibromyalgia; pVO2, peak volume oxygen consumption; MMSE, mini-mental state examination; GM, gray matter.